User profiles for Michael Mina
Michael J. Mina, MD, PhDHarvard School of Public Health, Harvard Medical School Verified email at hsph.harvard.edu Cited by 8068 |
[HTML][HTML] Rethinking Covid-19 test sensitivity—a strategy for containment
Rethinking Covid-19 Test Sensitivity As Covid-19 cases accelerate or plateau around the
world, we urgently need a point-of-care test that is inexpensive enough to use frequently, even …
world, we urgently need a point-of-care test that is inexpensive enough to use frequently, even …
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can
spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the …
spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the …
Estimating epidemiologic dynamics from cross-sectional viral load distributions
Estimating an epidemic’s trajectory is crucial for developing public health responses to
infectious diseases, but case data used for such estimation are confounded by variable testing …
infectious diseases, but case data used for such estimation are confounded by variable testing …
To interpret the SARS-CoV-2 test, consider the cycle threshold value
… Correspondence: MJ Mina, Harvard TH Chan School of Public Health, Kresge Building
506D, 677 Huntington Ave, Boston, MA 02115 (mmina@hsph.harvard.edu). … Tom1 and …
506D, 677 Huntington Ave, Boston, MA 02115 (mmina@hsph.harvard.edu). … Tom1 and …
COVID-19 testing: One size does not fit all
MJ Mina, KG Andersen - Science, 2021 - science.org
Tests for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were
developed within days of the release of the virus genome (1). Multiple countries have been …
developed within days of the release of the virus genome (1). Multiple countries have been …
[HTML][HTML] Antibody testing will enhance the power and accuracy of COVID-19-prevention trials
M Lipsitch, R Kahn, MJ Mina - Nature Medicine, 2020 - nature.com
Researchers starting clinical trials of prevention measures for COVID-19 have a unique window
of opportunity for collecting blood from the participants, at baseline and at the end of the …
of opportunity for collecting blood from the participants, at baseline and at the end of the …
[HTML][HTML] Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
1 Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute
coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart …
coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart …
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Measles virus is directly responsible for more than 100,000 deaths yearly. Epidemiological
studies have associated measles with increased morbidity and mortality for years after …
studies have associated measles with increased morbidity and mortality for years after …
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr …
nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr …
Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality
Immunosuppression after measles is known to predispose people to opportunistic infections
for a period of several weeks to months. Using population-level data, we show that measles …
for a period of several weeks to months. Using population-level data, we show that measles …